All News
Filter News
Found 806,114 articles
-
Neoleukin Therapeutics Announces Multiple Presentations at American Association for Cancer Research (AACR) Annual Meeting
3/8/2022
Neoleukin Therapeutics, Inc., “Neoleukin”, a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, announced three presentations at the upcoming American Association for Cancer Research Annual Meeting taking place April 8-13, 2022 in New Orleans, Louisiana.
-
Lilly Announces Details of Presentations at 2022 American Association for Cancer Research (AACR)
3/8/2022
Eli Lilly and Company announced that data from the pirtobrutinib and Verzenio® development programs will be presented at the 2022 American Association for Cancer Research Annual Meeting, April 8 - 13, 2022.
-
CytoSorbents Reports Fourth Quarter and Full Year 2021 Results and Provides 2022 Outlook
3/8/2022
CytoSorbents Corporation reported audited financial and operating results for the quarter and year ended December 31, 2021 and provides its 2022 outlook.
-
Anika Reports Fourth Quarter and Year-End 2021 Financial Results
3/8/2022
Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, reported financial results for its fourth quarter and full year ended December 31, 2021.
-
Merus Announces Publication of Abstract on MCLA-129 at the American Association for Cancer Research 2022 Annual Meeting
3/8/2022
Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced the publication of the abstract highlighting the mechanism of action of MCLA-129 on the American Association for Cancer Research website.
-
Gracell Biotechnologies Announces Details of Poster Presentation at AACR Annual Meeting 2022
3/8/2022
Gracell Biotechnologies Inc. announced the details of its poster presentation at the American Association for Cancer Research Annual Meeting 2022, being held from April 8-13 in New Orleans, Louisiana.
-
Hope Biosciences’ Cell Therapy Shown Safe, Beneficial for Rheumatoid Arthritis
3/8/2022
Hope Biosciences’ adipose-derived mesenchymal stem cells are effective in improving joint function in patients actively suffering from Rheumatoid Arthritis, finds a FDA-authorized Phase I/IIa pilot trial.
-
MannKind Corporation to Participate in Oppenheimer 32nd Annual Healthcare Conference
3/8/2022
MannKind Corporation announced that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a virtual presentation at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 4:00 pm.
-
Minerva Surgical Reports Fourth Quarter and Full-Year 2021 Financial Results
3/8/2022
Minerva Surgical, Inc., a woman's health company focused on the treatment of Abnormal Uterine Bleeding, reported fourth quarter and full-year financial results for the period ended December 31, 2021.
-
Erasca Announces Six Poster Presentations at the 2022 AACR Annual Meeting
3/8/2022
Erasca, Inc. announced the company will present six poster presentations at the upcoming American Association for Cancer Research Annual Meeting, taking place April 8-13, 2022, in New Orleans, Louisiana.
-
Teon Therapeutics Names Serge Messerlian as CEO
3/8/2022
Teon Therapeutics, a clinical-stage biopharmaceutical company targeting metabolic signaling pathways and pioneering the development of G-Protein Coupled Receptor immuno-oncology therapies in difficult-to-treat cancers, announced the appointment of Serge Messerlian as Chief Executive Officer and member of the board of directors.
-
Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Data Selected for Late-Breaking Presentation at 2022 American Academy of Dermatology Annual Meeting
3/8/2022
Cara Therapeutics, Inc. announced biomarker data from the KARE Phase 2 clinical trial evaluating Oral KORSUVA™ for the treatment of moderate-to-severe pruritus in atopic dermatitis patients will be presented in a late-breaking oral presentation at the 2022 American Academy of Dermatology Annual Meeting, to be held March 25-29, 2022, in Boston, MA.
-
Crystal Clinic Orthopaedic Center Pioneers Robotic Guidance System In Spine Surgery
3/8/2022
Crystal Clinic Orthopaedic Center is pioneering the use of the Mazor X Stealth™ robotic guidance system, as the first hospital in the region and one of only about 200 hospitals in the country to acquire this advanced technology for use in spine surgery.
-
Paratek Pharmaceuticals Announces the Publication of Data from an Investigator-Initiated Study of NUZYRA® (omadacycline) in a Hollow Fiber System Model Against Pulmonary Mycobacterium avium complex
3/8/2022
Paratek Pharmaceuticals, Inc. announced the publication of data from an investigator-initiated study evaluating the activity of NUZYRA® in a dynamic hollow fiber model of Mycobacterium avium complex pulmonary infection.
-
Flow Eighteen38 Receives €5 Million EUR (c.$5.58 Million USD) to Expand Production and Biophysical Capabilities
3/8/2022
Flow Eighteen38 announced a €5 million EUR investment into its protein production and biophysical characterization capabilities and services from its parent company, FairJourney Biologics S.A., leaders in the discovery and optimization of antibodies.
-
PharmAbcine to Present Updated Data of Its Anti-VISTA Antibody Candidate at AACR 2022
3/8/2022
PharmAbcine Inc., a clinical-stage biotech company focusing on the development of antibody therapeutics, announced that the Company will present the updated data of PMC-309, one of the Company's first immuno-oncology drug candidates, at AACR 2022.
-
Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021
3/8/2022
Invacare Corporation announced its financial results for the fourth quarter and year ended December 31, 2021.
-
Alaunos Therapeutics to Participate in the Oppenheimer 32nd Annual Healthcare Conference
3/8/2022
Alaunos Therapeutics, Inc. announced that the Company’s Chief Executive Officer, Kevin S. Boyle Sr., and Vice President of Research & Development, Drew Deniger, are scheduled to participate in the Oppenheimer 32nd Annual Healthcare Conference on Thursday, March 17, 2022 at 9:20am ET.
-
Meadowhawk Biolabs Launches Biotech/Pharma CRO on Two Coasts
3/8/2022
Meadowhawk Biolabs, Inc. is pleased to announce its launch of operations in the Boston and San Francisco areas.
-
Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022
3/8/2022
Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, has been named to Fast Company's prestigious annual list of the World's Most Innovative Companies for 2022.